Working… Menu
Trial record 1 of 19 for:    ALT-02
Previous Study | Return to List | Next Study

A Comparing Study Between ALT02(Trastuzumab Biosimilar) and Herceptin® in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03242239
Recruitment Status : Completed
First Posted : August 8, 2017
Last Update Posted : August 21, 2017
Cristália Produtos Químicos Farmacêuticos Ltda.
Information provided by (Responsible Party):
Alteogen, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 4, 2016
Actual Study Completion Date : September 30, 2016